PROTAC LRRK2 Degrader-3 primarily targets the LRRK2 protein through a PROTAC mechanism, exhibiting a DC50 of 0.17 nM. This compound effectively promotes the degradation of LRRK2, making it a valuable tool for research in Parkinson’s disease and inflammation. Its unique structure comprises a specific LRRK2 ligand, a Cereblon ligand, and an optimized linker, facilitating targeted therapeutic investigations.
PROTAC LRRK2 Degrader-3 primarily targets the LRRK2 protein through a PROTAC mechanism, exhibiting a DC50 of 0.17 nM. This compound effectively promotes the degradation of LRRK2, making it a valuable tool for research in Parkinson’s disease and inflammation. Its unique structure comprises a specific LRRK2 ligand, a Cereblon ligand, and an optimized linker, facilitating targeted therapeutic investigations.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
